🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
15.81
-0.21 (-1.31%)
Nov 20, 2026, 9:39 AM EST - Market open

Hims & Hers Health Earnings Call Transcripts

Fiscal Year 2026

  • Q3 revenue rose 49% YoY, while subscribers dipped QoQ amid deliberate marketing restraint and international brand migrations. Guidance reflects heavy international investment and deferred weight-loss revenue as the platform expands.

  • Q2 2026 saw 40% revenue growth to $753M and nearly 3M subscribers, driven by AI-powered care, international expansion, and strong weight loss and hormonal health demand. Adjusted EBITDA margin improved to 8%, with guidance raised for 2026 and robust investments in technology and global scale.

  • AGM 2026

    The meeting covered director elections, auditor ratification, and executive compensation, all of which were approved by majority or plurality vote. Stockholders could submit questions virtually, with responses to follow after the meeting.

  • Ambitious 2030 targets are set, driven by global expansion, specialty growth, and technology investments. Recent acquisitions and partnerships, especially with Eucalyptus and Novo Nordisk, accelerate international reach and deepen consumer engagement. AI and data are central to platform differentiation and operational efficiency.

  • Q1 2026 saw 4% revenue growth to $608M and a strategic pivot to branded weight loss products, driving rapid subscriber gains and engagement. Despite a GAAP net loss from restructuring, adjusted EBITDA was $44M, and full-year guidance was raised. Confidence remains high in achieving 2030 targets.

  • The platform has evolved from addressing stigmatized conditions to offering personalized, multi-condition treatments, leveraging technology and data to drive growth. Strategic investments in AI, diagnostics, and international expansion support ambitious revenue and margin targets, while marketing efficiency and brand strength continue to improve.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020